These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 9849312)

  • 1. Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy.
    Möttönen T; Paimela L; Leirisalo-Repo M; Kautiainen H; Ilonen J; Hannonen P
    Ann Rheum Dis; 1998 Sep; 57(9):533-9. PubMed ID: 9849312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history and prognosis of rheumatoid arthritis: association of radiographic outcome with process variables, joint motion and immune proteins.
    Graudal N
    Scand J Rheumatol Suppl; 2004; 118():1-38. PubMed ID: 15180092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of radiographic joint damage in patients with early rheumatoid arthritis.
    Jansen LM; van der Horst-Bruinsma IE; van Schaardenburg D; Bezemer PD; Dijkmans BA
    Ann Rheum Dis; 2001 Oct; 60(10):924-7. PubMed ID: 11557647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis.
    Combe B; Cantagrel A; Goupille P; Bozonnat MC; Sibilia J; Eliaou JF; Meyer O; Sany J; Dubois A; Daurès JP; Dougados M
    J Rheumatol; 2003 Nov; 30(11):2344-9. PubMed ID: 14677175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years.
    Eberhardt K; Fex E
    Br J Rheumatol; 1998 Dec; 37(12):1324-9. PubMed ID: 9973158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study.
    Courvoisier N; Dougados M; Cantagrel A; Goupille P; Meyer O; Sibilia J; Daures JP; Combe B
    Arthritis Res Ther; 2008; 10(5):R106. PubMed ID: 18771585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study.
    Bird P; Nicholls D; Barrett R; de Jager J; Griffiths H; Roberts L; Tymms K; McCloud P; Littlejohn G;
    Int J Rheum Dis; 2017 Apr; 20(4):460-468. PubMed ID: 28205333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions.
    Castrejón I; Dougados M; Combe B; Fautrel B; Guillemin F; Pincus T
    J Rheumatol; 2016 Jul; 43(7):1285-91. PubMed ID: 27084913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study.
    Gossec L; Dougados M; Goupille P; Cantagrel A; Sibilia J; Meyer O; Sany J; Daurès JP; Combe B
    Ann Rheum Dis; 2004 Jun; 63(6):675-80. PubMed ID: 15140774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability measured by the modified health assessment questionnaire in early rheumatoid arthritis: prognostic factors after two years of follow-up.
    Graell E; Vazquez I; Larrosa M; Rodríguez-Cros JR; Hernández MV; Gratacós J; Gómez A; Cañete JD; Gómez-Puerta JA; Sanmartí R
    Clin Exp Rheumatol; 2009; 27(2):284-91. PubMed ID: 19473570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation in two subsets of patients according to severity of radiographic damage.
    Meyer O; Combe B; Elias A; Benali K; Clot J; Sany J; Eliaou JF
    Ann Rheum Dis; 1997 Nov; 56(11):682-5. PubMed ID: 9462172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: a simple model of prediction from a conservatively treated community-based inception cohort.
    Le Loët X; Brazier M; Mejjad O; Boumier P; Daragon A; Gayet A; Pouplin S; Tron F; Zarnitsky C; Vittecoq O; Menard JF; Fardellone P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1739-47. PubMed ID: 20740612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.
    Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Okada T; van der Heijde D; Miyasaka N; Koike T
    Ann Rheum Dis; 2016 Jan; 75(1):75-83. PubMed ID: 26139005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city wide community based study.
    Suarez-Almazor ME; Tao S; Moustarah F; Russell AS; Maksymowych W
    J Rheumatol; 1995 Nov; 22(11):2027-33. PubMed ID: 8596139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of remission, erosive disease and radiographic progression in a Colombian cohort of early onset rheumatoid arthritis: a 3-year follow-up study.
    Quintana-Duque MA; Rondon-Herrera F; Mantilla RD; Calvo-Paramo E; Yunis JJ; Varela-Nariño A; Restrepo JF; Iglesias-Gamarra A
    Clin Rheumatol; 2016 Jun; 35(6):1463-73. PubMed ID: 27041382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reductions in Radiographic Progression in Early Rheumatoid Arthritis Over Twenty-Five Years: Changing Contribution From Rheumatoid Factor in Two Multicenter UK Inception Cohorts.
    Carpenter L; Norton S; Nikiphorou E; Jayakumar K; McWilliams DF; Rennie KL; Dixey J; Kiely P; Walsh DA; Young A;
    Arthritis Care Res (Hoboken); 2017 Dec; 69(12):1809-1817. PubMed ID: 28217885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy.
    Fedele AL; Petricca L; Tolusso B; Alivernini S; Canestri S; Di Mario C; Bosello SL; Ferraccioli G; Gremese E
    Scand J Rheumatol; 2018 Sep; 47(5):351-359. PubMed ID: 29542372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.
    Shu J; Bykerk VP; Boire G; Haraoui B; Hitchon C; Thorne JC; Tin D; Keystone EC; Pope JE;
    J Rheumatol; 2015 Nov; 42(11):2023-8. PubMed ID: 26329342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression.
    Dirven L; Visser K; Klarenbeek NB; Ewals JA; Han KH; Peeters AJ; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
    Scand J Rheumatol; 2012 Feb; 41(1):15-9. PubMed ID: 22103436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of 20-year outcome at onset of seropositive rheumatoid arthritis.
    Jäntti JK; Kaarela K; Luukkainen RK; Kautiainen HJ
    Clin Exp Rheumatol; 2000; 18(3):387-90. PubMed ID: 10895379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.